Caps monthly insulin costs for many insured Americans at $35 or less.
This bill would cap monthly out-of-pocket costs for many insured Americans' selected insulin products at $35 or 25% of the negotiated price, whichever is lower. It would also create a national resource center and 24/7 hotline to help uninsured individuals find affordable insulin options. Additionally, it would speed up the approval of certain biosimilar insulins.
Today, many insured Americans face varying and often high out-of-pocket costs for insulin, including deductibles. Uninsured individuals often struggle to find information about affordable insulin options or assistance programs. After this bill, most insured Americans would have their monthly insulin costs capped at $35 or less, and uninsured individuals would have a central, free resource to help them find affordable insulin and health insurance.
HR 10227 · 119th Congress · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers